Common Contracts
3 similar Employment Agreement contracts by Ocular Therapeutix, Inc
EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2024 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Pennsylvania
This EMPLOYMENT AGREEMENT (the “Agreement”) sets forth the terms and conditions of your employment with Ocular Therapeutix, Inc., and will be effective as of February 22, 2024 (the “Effective Date”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • March 6th, 2023 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) amends and restates the terms and conditions of your employment with Ocular Therapeutix, Inc., as set forth in your Employment Agreement dated November 30, 2020 (the “Existing Employment Agreement”), and will be effective as of September 28, 2022 (the “Effective Date”), provided that you remain employed by the Company as of the Effective Date. Until the Effective Date, the Existing Employment Agreement will remain in full force and effect and continue to govern your employment with the Company. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • March 6th, 2023 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) amends and restates the terms and conditions of your employment with Ocular Therapeutix, Inc., as set forth in your Employment Agreement dated July 9, 2019 (the “Existing Employment Agreement”), and will be effective as of October 13, 2022 (the “Effective Date”), provided that you remain employed by the Company as of the Effective Date. Until the Effective Date, the Existing Employment Agreement will remain in full force and effect and continue to govern your employment with the Company. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
